Burning Rock Biotech: Jing Rong, Licen Xu

Jing Rong has resigned from the board of directors of Burning Rock Biotech, and Licen Xu has been appointed as a new independent director. Xu has over 15 years of experience in the commercialization of biomedical products. She is the chief commercial officer of FlashDx, a molecular diagnostics point-of-care company, and an independent board member of synthetic DNA firm Ribbon Biolab. Xu also served as VP of strategic product management and lifecycle management at Roche Diagnostics and as VP of strategic marketing and product management at Illumina. She holds a PhD in molecular biology from the University of Zurich and an MS in biophysics from Tsinghua University.